GlaxoSmithKline

Read the Latest Trending News and Topics for Geeks

Breaking News about GlaxoSmithKline:


Gallery : GlaxoSmithKline

6 images
BRITAIN-PHARMA-HEALTH-COMPANY-EARNINGS-GSK-FILESBRITAIN-TELECOM-COMPANY-EARNINGS-BTHEALTH-FRANCE-BRITAIN-PHARMA-COURT-GLAXO

Sponsored Update


Tweets

 

Advertisement


Stalled Progress in the Fight Against HIV?

Source: Daily Finance

Has a stalemate been reached in the fight against HIV? After years of significant progress, a recent development could give the impression that progress might be stalled. In late April, the largest active stud ...
Full article at: Daily Finance  More like this  4 hours ago, 5:36pm CDT

Epizyme expected to hold IPO during week of May 27

Source: Boston Business Journal

BioFlash delivers the day's life sciences headlines from New England's innovation economy. Our daily opt-in push e-mail, BioFlash, delivers the day’s life sciences headlines to the desktops of executives and ...
Full article at: Boston Business Journal  More like this  4 hours ago, 5:34pm CDT

Latest stories

Nook Simple Touch w/ Glowlight discounted at Best Buy
Nook Simple Touch w/ Glowlight discounted at Best Buy
The Nook you can read in the dark is $40 off today only
 
Ferrari Versus Lamborghini - A Close Look At the Epic Battle
Ferrari Versus Lamborghini - A Close Look At the Epic Battle
It is one of the oldest rivalries of automotive history, Ferrari against Lamborghini. Auto Balla takes a closer look at the history of this epic sports car battle.
 
Tomb Raider PC download FALLS to $13.60
Tomb Raider PC download price FALL
Only $13.60 after coupon
 

Elan Rejects Royalty Offer Again - Analyst Blog

Source: NASDAQ

Join the NASDAQ Community today and get free, instant access to portfolios, stock ratings, real-time alerts, and more! Elan Corporation 's ( ELN ) Board of Directors recently rejected Royalty Pharma's offer for the third time. Following a thorough review ...
Full article at: NASDAQ  More like this  5 hours ago, 4:24pm CDT

Elan Rejects Royalty Offer Again - Analyst Blog

Source: Zacks Investment Research

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest. Today, you can see them free. Are you a new Zacks Member or a visitor to Zacks.com? One of the mo ...
Full article at: Zacks Investment Research  More like this  6 hours ago, 3:49pm CDT

No Fat in This Drug Launch

Source: Daily Finance

Prescriptions of Amarin's Vascepa are on a path to the moon. The company was nice enough to include a graph plotting prescriptions since the lipid-lowering drug launched at the end of January. (You can download a larger version here.) That trend ...
Full article at: Daily Finance  More like this  6 hours ago, 3:33pm CDT

Toxic drug abandoned in development being offered for sale online as performance enhancer for athletes

Source: The Province Daily News

TORONTO — Health Canada and drug maker GlaxoSmithKline have issued a warning that an experimental drug abandoned because it caused cancers in animal studies is being marketed to athletes as a performance-enhancing drug. Development was s ...
Full article at: The Province Daily News  More like this  6 hours ago, 3:24pm CDT

Exelixis Prepares For ASCO 2013, Stock Stays Rangebound

Source: Seeking Alpha

One of the biopharmaceutical companies that has been lagging the stellar performance of its peers is Exelixis (EXEL), developer of the compound cabozantinib. Cabo, which was FDA approved last year for the treatment of medullary thy ...
Full article at: Seeking Alpha  More like this  7 hours ago, 2:23pm CDT

Market Model Patterns of Change

Source: PaperCamp.com

Describe the business and explain the general pattern of change of the particular market model indicating how this change is likely to impact business operations. GlaxoSmithKline (GSK) is among the top 20 Global 500 companies and among the top five ...
Full article at: PaperCamp.com  More like this  8 hours ago, 1:44pm CDT



 

More From the Web

Viral Stories

 
 

Viral Videos and Photos